Yumanity Therapeutics Inc (NASDAQ:YMTX)

1.80
Delayed Data
As of Nov 30
 -0.005 / -0.28%
Today’s Change
0.95
Today|||52-Week Range
4.39
-39.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues4.3M8.4M5.3M2.8M
 
 
 
 
 
Depreciation And Amortization272.0K306.0K235.0K1.8M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses28.6M45.5M65.1M64.2M
 
 
 
 
 
Research And Development22.5M34.0M53.7M50.3M
 
 
 
 
 
Total Operating Expenses28.8M45.8M65.3M66.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-24.5M-37.5M-60.0M-63.2M
 
 
 
 
 
Extraordinary Credit0.000.0066.0K22.0K
 
 
 
Extraordinary Charge-63.0K-7.0K0.000.00
 
 
 
Interest Expense On Debt599.0K0.000.000.00
 
 
Other Expenses156.0K-16.0K-166.0K456.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.0M-37.2M-59.4M-61.8M
 
 
 
 
 
Preferred Dividend-1.7M-1.4M0.000.00
 
 
 
Net Income-25.0M-37.2M-59.4M-61.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M18.8M25.4M38.5M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M18.8M25.4M38.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.94-$2.06-$2.34-$1.61
 
 
 
 
 
EPS Diluted-$0.94-$2.06-$2.34-$1.61